V. G. Davydova

V. G. Davydova

Auto-generated profile, based on publicly available information

V. G. Davydova

Saint Petersburg City Hospital No 40

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2021 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
PDF file
AGA Y Gudkova
A Y Gudkova
SLS V Lapekin
S V Lapekin
TBT G Bezhanishvili
T G Bezhanishvili
MTM A Trukshina
M A Trukshina
VDV G Davydova
V G Davydova
ESE V Shlyakhto
E V Shlyakhto
There are presented the literature data and a description of the clinical course of the disease in isolated/predominant cardiac amyloidosis. Amyloid cardiomyopathy is the most common phenocopy of hypertrophic cardiomyopathy. The modern possibilities of non-invasive diagnostics using osteoscintigraphy for the differential diagnosis between amyloid cardiomyopathy caused by AL- and transthyretin amyloidosis are described in detail.

19 April 2020 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
PDF file
AGA. Ya. Gudkova
A. Ya. Gudkova
VDV. G. Davidova
V. G. Davidova
TBT. G. Bezhanishvili
T. G. Bezhanishvili
SPS. A. Pyko
S. A. Pyko
MZM. I. Zarayskiy
M. I. Zarayskiy
ЗИЗарайский Михаил Игоревич
Зарайский Михаил Игоревич
Aim. To study the levels of circulating microRNA-21 in patients with hypertrophic cardiomyopathy (HCM) of different ages. Materials and methods. The study included 49 patients with HCM. The proportion of females was 55.1%, males 44.9%. The average age was 50 [32; 65] (from 19 to 86 years). The control group for microRNA-21 included 44 healthy individuals, respectively, matched by the age and sex with the studied patients. Patients was made in accordance with the recommendations of the European society of cardiology. Plasma microRNA expression was determined by PCR with reverse transcription and real-time detection of results. The relative level of gene expression was calculated in accordance with the standard procedure 2-Ct. Results. Septal wall thickness at end diastole has a significant negative correlation with age in patients with HCM (r=-0.56; р0.001). PWTd (posterior wall thickness at end diastole) has a significant positive correlation with age in patients with HCM (r=0.67, р0.001). The level of circulating microRNA-21 in plasma is higher in patients with HCM compared to healthy individuals (5.28 [2.64; 13.96] and 0.84 [0.55; 1.23], respectively; p0.001). Significantly higher levels of microRNA-21 were found in young patients aged from 19 to 45 years with the symptomatic course of HCM (36.76 [5.66; 42.22]) compared to patients with asymptomatic course 45 years of age (2.81 [1.45; 5.28]; p0.002) and symptomatic patients 45 years (3.88 [2.16; 8.63]; p0.002).) The calculated risk of SCD was significantly higher in young symptomatic patients with HCM (6.01 [3.64; 9.67]) compared to patients with asymptomatic course 45 years (2.41 [1.21; 3.89]; p0.001) and symptomatic patients 45 years (2.56 [1.67; 4.41]; p0.001). Conclusion. The level of circulating microRNA-21 is significantly in patients with HCM compared to control group. The maximum level of circulating microRNA-21 was detected in patients with symptomatic course of HCM at the age of 45 years.

9 March 2018 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
APA. A. Poliakova
A. A. Poliakova
EBE. I. Baranova
E. I. Baranova
ESE. N. Semernin
E. N. Semernin
AKA. N. Krutikov
A. N. Krutikov
ОМО. В. Мельник
О. В. Мельник
AGA. Ya. Gudkova
A. Ya. Gudkova
ГЕНДЕРНЫЕ РАЗЛИЧИЯ КЛИНИЧЕСКОГО ТЕЧЕНИЯ И РЕМОДЕЛИРОВАНИЯ СЕРДЦА ПРИ ИДИОПАТИЧЕСКОЙ ГИПЕРТРОФИЧЕСКОЙ КАРДИОМИОПАТИИ В ПОЖИЛОМ ВОЗРАСТЕ

8 September 2020 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
TBT. G. Bezhanishvili
T. G. Bezhanishvili
AGA. Ya. Gudkova
A. Ya. Gudkova
VDV. G. Davydova
V. G. Davydova
SASofiya Andreeva
Sofiya Andreeva
AKA. N. Krutikov
A. N. Krutikov
ЕШЕ. В. Шляхто
Е. В. Шляхто
Aim. To analyze associations of interleukin-6 receptor gene ( IL6R ) polymorphism (rs2228145) with the clinical course characteristics of hypertrophic cardiomyopathy (HCM) in groups of patients with various cardiometabolic risk factors Material and methods. The sample consisted of 123 patients with HCM. The age of the included patients ranged from 18 to 91 years (59 [41; 66.5]), of whom 59 were men, 64 — women. Two age groups were identified: the first group included patients from 18 to 44 years old, the second — 45 years and older. The control group consisted of 200 people without cardiovascular diseases and other severe comorbidities. For genetic testing, DNA was isolated from peripheral blood lymphocytes. Genotyping of the IL6R gene polymorphism (rs2228145) was carried out by realtime polymerase chain reaction. Results. A significant prevalence of CC genotype of the IL6R gene polymorphism (rs2228145) was revealed in patients aged ³45 years compared with the control group, which occurred in 14,1% and 3,0% of cases, respectively (CC:AC+AA, odds ratio (OR), 0,885, 95% confidence interval (CI), 1,051-0,691, p=0,006), and insignificant prevalence of C allele in this group, which does not reach the level of significance (A:C, OR, 0,870, 95% CI, 0,427-1,02, p=0,06). The prevalence of CC genotype (15,1% vs 3,0%) and C allele (39,0% vs 29,0%) was revealed in patients with HCM in combination with hypertension (HTN) compared with the control group (CC:AS+AA, OR=0,174, 95% CI, 0,047-0,650), p=0,004); (A:C, OR=0,638, 95% CI, 0,406-1,002), p=0,05). Conclusion. The relationship between the IL6R gene polymorphism (rs2228145) and HTN in patients with HCM was confirmed. The presence of CC genotype and C allele of the rs2228145 IL6R gene polymorphism is significantly more common in patients with HCM with the disease onset ³45 years of age. The presence of CC genotype and C allele of the IL6R gene polymorphism (rs2228145) is associated with HTN in patients with HCM.

7 September 2024 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
VDV. G. Davydova
V. G. Davydova
AGA. Ya. Gudkova
A. Ya. Gudkova
AKA. N. Krutikov
A. N. Krutikov
APA. A. Poliakova
A. A. Poliakova
AKAnna Kostareva
Anna Kostareva
Aim. To study the clinical, morphological and genetic characteristics of young patients with hypertrophic cardiomyopathy (HCM) with indications for primary and secondary prevention of sudden cardiac death (SCD).Material and methods. The study included 44 young patients with HCM who were examined in accordance with national clinical guidelines for HCM (2020). The AHA HCM SCD Calculator was used to calculate the risk of SCD. The genetic study was performed using a target panel of 108 genes associated with cardiomyopathies.Results. In the study cohort, young patients in 72,7% of cases (n=32) had from 1 to 3 cardiometabolic risk factors (on average 1,53±0,8).The age of 18 patients with indications for implantable cardioverter-defibrillator (ICD) ranged from 18 to 44 years (28,8±2,2). The age at diagnosis was 18,5±7,4 years, while the asymptomatic period lasted 6,4±0,9 years. The estimated risk of SCD ranged from 3,11 to 20,71% (6,15 [4,67; 7,32]). In 83,3% of cases (n=15), familial HCM was diagnosed, while 50% (n=9) had a positive family history of SCD. In the subgroup of patients with indications for ICD, genetic variants with pathogenic significance (class IV and V) encoding the production of sarcomere proteins were detected in 6 of 9 probands (66,7%).In patients with indications for ICD (n=18), compared to patients without it (n=26), the diagnosis of HCM was more often established in childhood and adolescence (61,1% vs 23%, p=0,01). In patients with indications for ICD, the reverse curvature hypertrophy of the interventricular septum was significantly more often diagnosed (72,2% vs 38,5%, p=0,028). Among patients with indications for ICD, the proportion of people with low physical activity was 50% (n=9), of which 55,6% (n=5) were diagnosed with overweight/class 1 obesity.Conclusion. Childhood and adolescence at the time of diagnosis of HCM and reverse curvature hypertrophy of the interventricular septum are significantly more common in young patients with indications for ICD.

27 October 2022 in The Scientific Notes of the Pavlov University
Verified
Journal Article
Open access
PDF file
VDV. G. Davydova
V. G. Davydova
EBElena Baranova
Elena Baranova
TBT. G. Bezhanishvili
T. G. Bezhanishvili
AKA. N. Krutikov
A. N. Krutikov
APA. A. Poliakova
A. A. Poliakova
AGA. Ya. Gudkova
A. Ya. Gudkova
The objective was to study the clinical features of symptomatic hypertrophic cardiomyopathy (HCM) depending on the age of onset and the presence of cardiometabolic risk factors.Methods and materials. From 2014 to 2020, 250 patients were examined, 100 patients with symptomatic HCM aged 18 to 86 years were included in the study.Results. The incidence of arterial hypertension (AH), obesity, and angina syndrome was significantly higher in patients with HCM aged 45 years and older. The patients with HCM and associated obesity had greater left ventricular end-diastolic dimension and left antero-posterior size regardless of the age of onset of clinical manifestations. The young patients with HCM and associated obesity had more often AH. Patients with HCM with the disease onset ≥ 45 years of age and associated obesity had greater left ventricular posterior wall thickness, left ventricular end-diastolic dimension index. In this group of patients, pulmonary hypertension was more often diagnosed.Conclusion. Obesity and other cardiometabolic risk factors are predictors of the progressive course of HCM, which points the need for their prevention and timely correction.